    #Adrenergic Drugs {#id}

Adrenergic drugs are sympathomimetic based on a **benzene ring**, with different amine side chains. When a hydroylgroup is present at the C3 and C4 positions, it is known as a **catecholamine**. All adrenergic act via either a dopamine (D) or adrenoreceptors (α and β). **Direct-acting** stimulate the receptor, whilst **indirect-acting** release noradrenaline to cause sympathomimetic effects.

##Receptor types and action
All are G-protein coupled receptors, which **except in α1** receptors either enhance or inhibit adenylate cyclase to raise or lower (respectively) cAMP and cause the cellular effect.


Sympathomimetics can be classified as **natural catecholamines**, **synthetic catecholamines**, or **"other"**.

##Comparison of Commonly Used Adrenergic Agents
|Properties|Noradrenaline|Adrenaline|Phenylephrine|Metaraminol|
|--|--|--|--|--|--|--|--| 
|**Class**|Natural Catecholamine|Natural Catecholamine|Synthetic sympathomimetic|Synthetic amine| 
|**Uses**|↑ SVR|Cardiac arrest, anaphylaxis, inotropy, chronotropy, adjunct in local anaesthetics|↑ SVR|↑ SVR| 
|**Dosing**| Start at 0.05µg/kg/min|Infusion starts at: 0.01µg/kg/min|Bolus start at 50-100mcg|Bolus 0.5-2mg|
|**Route**|IV|IV/IM/ETT/SC|IV/IM/SC|IV| 
|**Presentation**|Clear, colourless solution|A clear, colourless solution typically at 0.1-1mg/ml|Clear, colourless solution at 100mcg/ml || 
|**Absorption**|IV only|Variable ETT and SC absorption|IM onset 15 minutes, duration up to 1 hour|
|**Metabolism**| t<sub>1/2</sub> 2min. Metabolised by mitochondrial MAO and COMT within liver, kidney, and blood to VMA and metadrenaline. |t<sub>1/2</sub> 2min. Metabolised by mitochondrial MAO and COMT within liver, kidney, and blood to VMA and metadrenaline. |Hepatic by MAO||
|**Elimination**| Urinary excretion of metabolites| Urinary excretion of metabolites||| 
|**Mechanism of action** |α>β|β>α at lower doses|α1 only|α1 | 
|**Respiratory**|| ↑ MV, bronchodilation|||
|**CVS**|↑SVR, ↑ Myocardial O<sub>2</sub> consumption, ↑ Coronary flow.| Inotropy, ↑ HR, ↑ SVR, ↑ BP, ↑ myocardial O<sub>2</sub> consumption. Arrythmogenic.| ↑ SVR, potential reflex bradycardia. Not arrythmogenic.|↑ SVR, reflex bradycardia | 
|**CNS**||↑ Pain threshold, ↑MAC||| 
|**MSK**|Necrosis with extravasation|Necrosis with extravasation|||
|**Renal**|↓RBF| ↓RBF and ↑ in sphincter tone||↓RBF|
|**Metabolic**||↑BMR, ↑ lipolysis, ↑gluconeogenesis and BSL, ↑ Lactate|||
|**GU**| ↓ Uterine blood flow and foetal bradycardia|||↓ Uterine blood flow|


##Comparison of Less Common Adrenergic Agents
|Properties|Dopamine|Isoprenaline|Dobutamine|
|--|--|--|--|--|--|--|--|
|**Class**|Natural Catecholamine|Synthetic Catecholamine|Synthetic Catecholamine|
|**Uses**|Haemodynamic support | Severe bradycardia|Stress testing, increasing CO |
|**Dosing**|Start 1µg/kg/min|Infusion from 0.5-10µg/min| 0.5-20µg/kg/min |
|**Route**|IV|IV|IV|
|**Presentation**|Clear, colourless solution with 200mg or 800mg in water |Clear solution at 1mg/ml| 250mg dobutamine in 20ml water|
|**Metabolism**|t<sub>1/2</sub> 3 min. 25% of dose converted to noradrenaline. Remainder is metabolised by MAO and COMT similar to nor/adrenaline. |Hepatic by COMT|t<sub>1/2</sub> 2 min. COMT to inactive metabolites.|
|**Elimination**||| Urinary excetion of unchanged drug and metabolites|
|**Mechanism of action** |D<sub>1</sub>, D<sub>2</sub>; β>α at lower dose||β<sub>1</sub>>β<sub>2</sub>, D<sub>2</sub>|
|**Respiratory**||Potent bronchodilation|Bronchodilation|
|**CVS**|| ↑ SVR, potential reflex bradycardia. Not arrythmogenic. | ↑ HR, CO, contractility, and automaticity. Β<sub>2</sub> effects may drop BP.
|**CNS**|Inhibits prolactin|Stimulant|Tremor|
|**MSK**|Necrosis with extravasation|||
|**Renal**|||↑ RBF and ↑ urinary output with no improvement in renal function|
|**Metabolic**||||
|**GU**| |||

##References
Peck and Hill